These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Brandenburg K, Jürgens G, Müller M, Fukuoka S, Koch MH. Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403 [Abstract] [Full Text] [Related]
5. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Afeltra A, Caccavo D, Ferri GM, Addessi MA, De Rosa FG, Amoroso A, Bonomo L. Clin Exp Immunol; 1997 Aug; 109(2):279-85. PubMed ID: 9276523 [Abstract] [Full Text] [Related]
7. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. Caccavo D, Pellegrino NM, Altamura M, Rigon A, Amati L, Amoroso A, Jirillo E. J Endotoxin Res; 2002 Aug; 8(6):403-17. PubMed ID: 12542852 [Abstract] [Full Text] [Related]
11. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477. Mashimo J, Mizutani T, Mita A, Kasai N. Microbiol Immunol; 1991 Jul; 35(6):423-34. PubMed ID: 1921759 [Abstract] [Full Text] [Related]
19. Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor. Mayoral JL, Dunn DL. J Surg Res; 1990 Oct; 49(4):287-92. PubMed ID: 1699085 [Abstract] [Full Text] [Related]